Peter Boström

High‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay (2025)

Journal of Extracellular Biology

Islam, Md. Khirul; Mahmud, Imran; Ali, Klinton; Salminen, Teppo; Taimen, Pekka; Boström, Peter J.; Leivo, Janne; Lamminmäki, Urpo; Martiskainen, Iida

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025)

World Journal of Urology

Rinderknecht, Emily; Claps, Francesco; Boström, Peter J.; Shariat, Shahrokh F.; Neuzillet, Yann; Zlotta, Alexandre R.; Trombetta, Carlo; Eckstein, Markus; Lijnen, Renee A. G.; Mertens, Laura S.; Bussani, Rossana; Burger, Maximilian; van Leenders, Geert J. L. H.; Boormans, Joost L.; Wullich, Bernd; Hartmann, Arndt; Pavan, Nicola; Pouessel, Damien; van der Kwast, Theo H.; Allory, Yves; Zuiverloon, Tahlita C. M.; Lotan, Yair; van Rhijn, Bas W. G.; Mayr, Roman

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes (2025)

Cancers

Nikulainen, Ilkka; Salminen, Antti P.; Högerman, Mikael; Seikkula, Heikki; Boström, Peter J.; The Finnish National Cystectomy Database Research Group

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer (2025)

Scandinavian Journal of Urology

Ettala, Otto; Bergroth, Robin; Riikonen, Jarno; Boström, Peter; Koskimäki, Juha; Kuisma, Jani; Rannikko, Antti; Vaarala, Markku; Sanda, Martin G; Santti, Henrikki

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)

BJU International

Viitala, Antti; Anttinen, Mikael; Mäkelä, Pietari; Pärssinen, Heikki; Nurminen, Pertti; Sainio, Teija; Saunavaara, Jani; Taimen, Pekka; Sequeiros, Roberto Blanco; Boström, Peter J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)

Journal of Magnetic Resonance Imaging

Parhiala, Laura; Knaapila, Juha; Jambor, Ivan; Verho, Janne; Syvänen, Kari; Aronen, Hannu; Boström, Peter; Ettala, Otto

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study (2025)

Clinica Chimica Acta

Khan, Md. Ferdhos L.; Perez, Ileana M.; Kekki, Henna; Taimen, Pekka; Boström, Peter J.; Jambor, Ivan; Ettala, Otto; Pahikkala, Tapio; Pettersson, Kim

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer (2025)

European Urology Open Science

Anttinen, Mikael; Mäkelä, Pietari; Nurminen, Pertti; Pärssinen, Heikki; Malaspina, Simona; Sainio, Teija; Högerman, Mikael; Taimen, Pekka; Blanco Sequeiros, Roberto; Boström, Peter J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer (2025)

European Journal of Nuclear Medicine and Molecular Imaging

Kivikallio, Aino; Malaspina, Simona; Saarinen, Irena; Seppänen, Marko; Anttinen, Mikael; Jambor, Ivan; Verho, Janne; Kemppainen, Jukka; Aronen, Hannu J.; Boström, Peter J.; Ettala, Otto; Taimen, Pekka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Accuracy of cognitive vs software‐guided MRI‐targeted biopsy in predicting final grading at prostatectomy (2025)

BJU International

Finati, Marco; Ricapito, Anna; Musi, Gennaro; Rocco, Bernardo; Porpiglia, Francesco; Antonelli, Alessandro; Gontero, Paolo; Boström, Peter; Schips, Luigi; Simone, Giuseppe; Mirone, Vincenzo; Carmignani, Luca; Lodovico, Giuseppe Mario; Montanari, Emanuele; Sciarra, Alessandro; Bove, Pierluigi; Jambor, Ivan; Trombetta, Carlo; Ficarra, Vincenzo; Carrieri, Giuseppe; Falagario, Ugo Giovanni; PROMOD Working Group

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Peter

Boström

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

High‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay (2025)

Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025)

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes (2025)

Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer (2025)

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)

Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)

Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study (2025)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer (2025)

Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer (2025)

Accuracy of cognitive vs software‐guided MRI‐targeted biopsy in predicting final grading at prostatectomy (2025)